Baron Jean Stéphenne
Chairman presso CUREVAC N.V.
Patrimonio netto: 23 345 $ in data 29/02/2024
Profilo
Il barone Jean Stphenne è un uomo d'affari belga che è stato a capo di 23 società diverse. Attualmente, occupa la posizione di Presidente di Nanocyl SA, Presidente del Parc d'aventures scientifiques SCRL, Presidente di Bone Therapeutics SA, Presidente di BePharBel Manufacturing SA, Presidente di OncoDNA SA, Presidente di Innoste SA, Presidente del Consiglio di sorveglianza di CureVac NV, Presidente del Consiglio di sorveglianza di CureVac AG (una filiale di CureVac NV), Presidente e Amministratore delegato di Recherche Et Industrie Therapeutiques, Presidente di TiGenix NV e Presidente di Vesalius Biocapital II SA SICAR. È anche Presidente della Fondazione Universitaria e Presidente dell'Universit Catholique de Louvain e nel consiglio di amministrazione di altre 6 società. Il barone Jean Stphenne è stato in precedenza presidente di Ion Beam Applications SA, presidente e presidente di Gsk Biologicals, presidente di Union Wallonne des Entreprises, presidente e presidente di GlaxoSmithKline Biologicals SA, presidente di Aseptic Technologies NV, presidente di Vesalius Biocapital I SA SICAR, presidente di Wallon Institute for Life Lead Sciences e presidente di BioWin ASBL. Il signor Stphenne ha conseguito una laurea presso l'Universit Catholique de Louvain e una laurea presso la Facult Universitaire des Sciences Agronomiques de Gembloux.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CUREVAC N.V.
0.00% | 31/03/2023 | 6 826 ( 0.00% ) | 23 345 $ | 29/02/2024 |
Posizioni attive di Baron Jean Stéphenne
Società | Posizione | Inizio |
---|---|---|
CUREVAC N.V. | Chairman | 01/08/2015 |
INTEGRAGEN | Chairman | - |
Vesalius Biocapital II SA SICAR
Vesalius Biocapital II SA SICAR Investment ManagersFinance Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Chairman | - |
Innoste SA | Chairman | - |
N-Side SA
N-Side SA Miscellaneous Commercial ServicesCommercial Services N-Side SA engages in management consulting services. The firm implements integrated software solutions to enable optimal decision-making. The company was founded by Philippe Chevalier in 2000 and is headquartered in Louvain-la-Neuve, Belgium. | Director/Board Member | 01/01/2015 |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chairman | 02/04/2020 |
Belgian Foundation Against Cancer | Director/Board Member | - |
Université Catholique de Louvain | Chairman | - |
Recherche Et Industrie Therapeutiques | Chief Executive Officer | 01/01/1974 |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Precedenti posizioni note di Baron Jean Stéphenne
Società | Posizione | Fine |
---|---|---|
░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ | ░░░░░░░░ | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
Formazione di Baron Jean Stéphenne
Faculté Universitaire des Sciences Agronomiques de Gembloux | Undergraduate Degree |
Université Catholique de Louvain | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
ION BEAM APPLICATIONS, SA | Health Technology |
GROUPE BRUXELLES LAMBERT SA | Finance |
INTEGRAGEN | Health Services |
BNP PARIBAS FORTIS SA | Finance |
Aziende private | 30 |
---|---|
TiGenix NV
TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Aseptic Technologies SA
Aseptic Technologies SA Medical SpecialtiesHealth Technology Aseptic Technologies NV engages in the development and manufacture of aseptic production equipment. It offers AT-closed Vial, filling lines, isolator and barrier, and kits for aseptic filling. The company was founded in 2002 and is headquartered in Gembloux, Belgium. | Health Technology |
Henogen SA
Henogen SA Pharmaceuticals: MajorHealth Technology Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium. | Health Technology |
Nanocyl SA
Nanocyl SA SteelNon-Energy Minerals Nanocyl SA specializes in manufacturing of industrial multiwall carbon nanotubes. It produces synthetic materials and manufacture equipments for the automotive and electronic industries. It products include Plasticyl, Epocyl, Aquacyl, Elastocyl, Orgacyl and research grades. The firm also develops tailor made solutions for the aeronautic, construction, sports, and marine industries. The company was founded in 2002 and is headquartered in Sambreville, Belgium. | Non-Energy Minerals |
N-Side SA
N-Side SA Miscellaneous Commercial ServicesCommercial Services N-Side SA engages in management consulting services. The firm implements integrated software solutions to enable optimal decision-making. The company was founded by Philippe Chevalier in 2000 and is headquartered in Louvain-la-Neuve, Belgium. | Commercial Services |
Vesalius Biocapital I SA SICAR
Vesalius Biocapital I SA SICAR Investment ManagersFinance Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Finance |
Opus-Invest NV
Opus-Invest NV Construction MaterialsNon-Energy Minerals Opus-Invest NV operates as a holding company with interests in construction, electricity, and renovation services. The company was founded by Eugène Ronveaux and is headquartered in Ciney, Belgium. | Non-Energy Minerals |
Union Wallonne des Entreprises
Union Wallonne des Entreprises Miscellaneous Commercial ServicesCommercial Services Union Wallonne des Entreprises (UWE) is an organization of private employers that aims to accelerate the creation and development of economic activity in historic Wallonia. UWE is based in Wavre, Belgium. UWE comprises thematic commissions, sectoral federations, and associated member companies. The organization provides an extranet for its members, publishes an agenda, and releases position papers. | Commercial Services |
Federation of Enterprises in Belgium
Federation of Enterprises in Belgium Miscellaneous Commercial ServicesCommercial Services Federation of Enterprises in Belgium ASBL/VZW fka Federation des Entreprises de Belgique is the only multi-sector employers' organization representing companies in all three regions of Belgium. Its members, Belgium's leading sectoral federations, represent companies in key industrial and service sectors. The company was founded in 1973 and is headquartered in Brussels, Belgium. | Commercial Services |
Sparkoh CV
Sparkoh CV Real Estate DevelopmentFinance Parc d'aventures scientifiques SCRL operates a scientific convention center. It provides space for conducting exhibitions and shows related to science, technology and society. The company is headquartered in Frameries, Belgium. | Finance |
Auguria Residential Real Estate Fund (Brussels) | |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
Wallon Institute for Life Lead Sciences | |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Commercial Services |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Technology |
Vesalius Biocapital II SA SICAR
Vesalius Biocapital II SA SICAR Investment ManagersFinance Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Finance |
University Foundation | Miscellaneous |
BePharBel Manufacturing SA
BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Health Technology |
Fondation Belge Contre Le Cancer | |
OncoDNA SA
OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Health Services |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The private company is based in Reinach, Switzerland. | Health Technology |
Gsk Biologicals
Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Commercial Services |
Belgian Foundation Against Cancer | |
CureVac NV | |
Recherche Et Industrie Therapeutiques | |
BESIX Group NV
BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Industrial Services |
Theravectys SAS
Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Health Technology |
Innoste SA |